The document discusses the global antifungal drugs market. It provides an analysis of the market by region, including North America, Europe, Asia Pacific, and the rest of the world. It also analyzes the market by country and by drug class and therapeutic indications. The market is segmented by drug class into azoles, echinocandins, polyenes, and others. The therapeutic indications covered are candidiasis, aspergillosis, dermatophytosis, and others. The market is forecast to grow steadily between 2013-2023 driven by increasing fungal infections globally.

1. • By Region: North America, Europe,
Asia Pacific, and Rest of the world.
• By Country - US, Canada, UK,
Germany, France, , Italy, China,
Japan, India.
January 2019
Global Antifungal Drugs Market: Analysis By Drug Class (Azoles,
Echinocandins, Polyenes, Others), By Therapeutic Indications
(Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By
Country (2019 Edition): Opportunities and Forecast (2013-2023)

2. Scope of the Report – Anti-Fungal Drugs Market
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Global
Market (By Value)
By Drugs Type,
By Value
Azoles           
Polyenes           
Echinocandins           
Other           
By Therapeutic
Indications,
By Value
Aspergillosis           
Dermatophyt
osis           
Candidiasis           
Others           
Regional
By Drugs Type,
By Value
Azoles           
Polyenes           
Echinocandins           
Other           
By Therapeutic
Indications,
By Value
Aspergillosis           
Dermatophyt
osis           
Candidiasis           
Others           
Historical Forecast
2

3. Scope of the Report – Anti-Fungal Drugs Market
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Country
By Drugs Type,
By Value
Azoles           
Polyenes           
Echinocandins           
Other           
By Therapeutic
Indication ,
By Value
Aspergillosis           
Dermatophyt
osis           
Candidiasis           
Others           
By Company
Merck & Co., GSK, Astellas Pharma, Sanofi, Abbott Laboratories, Bayer, Kramer Laboratories, Novartis, Pfizer.
By Region
North America, Europe, APAC and ROW.
By Country
USA, Canada, Germany, France, UK, China, Japan and India.
Historical Forecast
3

4. Table of Content
S.No Particulars Page No.
1. Research Methodology 27
2. Executive Summary 28
3. Strategic Recommendation 29
3.1 Improve Existing Antifungals 30
3.2 Asia Pacific Region to witness the fastest growth 31
4. Antifungal Drugs Products Outlook 32
5. Global Antifungal Drugs Market: Growth and Forecast 40
5.1 By Value (2013-2017) 41
5.2 By Value (2018-2023) 53
6. Global Antifungal Drugs Market: Segmental Analysis 54
6.1 Global Antifungal Drugs Market Size, By Drug Class: Breakdown (%) 55
6.1.1 Global Antifungal Drugs Market Size, By Drug Class, 2017 (%) 55
6.1.2 Global Antifungal Drugs Market Size, By Drug Class, 2023 (%) 56
6.2 Global Azole Class Antifungal Drugs Market Size, By Value (2013-2023) 57
6.3 Global Echinocandins Class Antifungal Drugs Market Size, By Value (2013-2023) 58
6.4 Global Polyenes Antifungal Drugs Market Size, By Value (2013-2023) 59
6.5 Global Other Antifungal Drugs Market Size, By Value (2013-2023) 60
6.6 Global Antifungal Drugs: Market Attractiveness, By Drug Class 61
6.7 Global Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%) 63
6.7.1 Global Aspergillus Antifungal Drugs Market Size, By Value (2013-2023) 65
6.7.2 Global Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023) 65
4

5. Table of Content
S.No Particulars Page No.
6.7.3 Global Candidiasis Antifungal Drugs Market Size, By Value (2013-2023) 65
6.6.2 Global Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023) 65
7. Global Antifungal Drugs Market: Regional Analysis 66
7.1 Global Antifungal Drugs Market Size, By Region : Breakdown (%) 67
7.1.1 Global Antifungal Drugs Market Size, By Region, 2017 (%) 67
7.1.2 Global Antifungal Drugs Market Size, By Region, 2023 (%) 67
8. North America Antifungal Drugs Market: Growth and Forecast 68
8.1 North America Antifungal Drugs Market: Segmental Analysis 68
8.2 North America Antifungal Drugs Market Size, By Drug Class: Breakdown (%) 75
8.2.1 North America Antifungal Drugs Market Size, By Drug Class, 2017 (%) 75
8.2.2 North America Antifungal Drugs Market Size, By Drug Class, 2023 (%) 75
8.3 North America Azoles Antifungal Drugs Market Size, By Value (2013-2023) 76
8.4 North America Echinocandins Antifungal Drugs Market Size, By Value (2013-2023) 76
8.5 North America Polyenes Antifungal Drugs Market Size, By Value (2013-2023) 76
8.6 North America Others Antifungal Drugs Market Size, By Value (2013-2023) 76
8.7 North America Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%) 77
8.7.1 North America Aspergillus Antifungal Drugs Size, By Value (2013-2023) 78
8.7.2 North America Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023) 78
5

6. Table of Content
S.No Particulars Page No.
8.7.3 North America Candidiasis Antifungal Drugs Size, By Value (2013-2023) 78
8.7.4 North America Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023) 78
8.8 North America Antifungal Drugs Market: Country Analysis (U.S and Canada) 80
8.8.1 U.S Antifungal Drugs Market, By Value (2013-2023) 83
8.8.2 U.S Antifungal Drugs Market, By Drug Class, By Value (2013-2023) 89
8.8.3 U.S Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023) 91
8.8.4 Canada Antifungal Drugs Market, By Value (2013-2023) 94
8.8.5 Canada Antifungal Drugs Market, By Drug Class, By Value (2013-2023) 100
8.8.6 Canada Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023) 102
9. Europe Antifungal Drugs Market: Growth and Forecast 104
9.1 Europe Antifungal Drugs Market: Segmental Analysis 104
9.2 Europe Antifungal Drugs Market Size, By Drug Class: Breakdown (%) 110
9.1.2 Europe Antifungal Drugs Market Size, By Drug Class, 2017 (%) 110
9.1.3 Europe Antifungal Drugs Market Size, By Drug Class, 2023 (%) 110
6

7. Table of Content
S.No Particulars Page No.
9.3 Europe Azoles Antifungal Drugs Market Size, By Value (2013-2023) 111
9.4 Europe Echinocandins Drugs Market Size, By Value (2013-2023) 111
9.5 Europe Polyenes Antifungal Drugs Market Size, By Value (2013-2023) 111
9.6 Europe Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%) 112
9.6.1 Europe Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023) 113
9.6.2 Europe Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023) 113
9.6.3 Europe Candidiasis Antifungal Drugs Market Size, By Value (2013-2023) 113
9.6.4 Europe Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023) 113
9.7 Europe Antifungal Drugs Market: Country Analysis (Germany, France, Italy, U.K) 115
9.7.1 Germany Antifungal Drugs Market, By Value (2013-2023) 118
9.7.2 Germany Antifungal Drugs Market, By Drug Class, By Value (2013-2023) 124
9.7.3 Germany Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023) 126
9.7.4 France Antifungal Drugs Market, By Value (2013-2023) 129
9.7.5 France Antifungal Drugs Market, By Drug Class, By Value (2013-2023) 134
9.7.6 France Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023) 136
9.7.7 UK Antifungal Drugs Market, By Value (2013-2023) 139
9.7.6 UK Antifungal Drugs Market, By Drug Class, By Value (2013-2023) 144
9.7.7 UK Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023) 146
7

8. Table of Content
S.No Page No.
10. APAC Antifungal Drugs Market: Growth and Forecast 149
10.1 APAC Antifungal Drugs Market: Segmental Analysis 149
10.2 APAC Antifungal Drugs Market Size, By Drug Class: Breakdown (%) 154
10.2.1 APAC Antifungal Drugs Market Size, By Drug Class, 2017 (%) 154
10.2.2 APAC Antifungal Drugs Market Size, By Drug Class, 2023 (%) 154
10.3 APAC Azole Antifungal Drugs Market Size, By Value (2013-2023) 155
10.4 APAC Echinocandins Antifungal Drugs Market Size, By Value (2013-2023) 155
10.5 APAC Polyenes Antifungal Drugs Market Size, By Value (2013-2023) 155
10.6 APAC Other Antifungal Drugs Market Size, By Value (2013-2023) 155
10.7 APAC Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%) 156
10.7.1 APAC Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023) 157
10.7.2 APAC Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023) 157
10.7.3 APAC Candidiasis Antifungal Drugs Market Size, By Value (2013-2023) 157
10.7.4 APAC Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023) 157
8

9. Table of Content
S.No Particulars Page No.
10.8 APAC Antifungal Drugs Market: Country Analysis (China, Japan, and India) 158
10.8.1 China Antifungal Drugs Market, By Value (2013-2023) 162
10.8.2 China Antifungal Drugs Market, By Drug Class, By Value (2013-2023) 168
10.8.3 China Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023) 170
10.8.4 Japan Antifungal Drugs Market, By Value (2013-2023) 173
10.8.5 Japan Antifungal Drugs Market, By Drug Class, By Value (2013-2023) 179
10.8.6 Japan Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023) 181
10.8.7 India Antifungal Drugs Market, By Value (2013-2023) 184
10.8.8 India Antifungal Drugs Market, By Drug Class, By Value (2013-2023) 189
10.8.9 India Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023) 191
11. ROW Antifungal Drugs Market: Growth and Forecast 193
11.1 ROW Antifungal Drugs Market: Segmental Analysis 193
11.2 ROW Antifungal Drugs Market Size, By Drug Class: Breakdown (%) 201
11.1.1 ROW Antifungal Drugs Market Size, By Drug Class, 2017 (%) 201
11.1.2 ROW Antifungal Drugs Market Size, By Drug Class, 2023 (%) 201
9

10. Table of Content
S.No Page No.
11.3 ROW Azole Antifungal Drugs Market Size, By Value (2013-2023) 202
11.4 ROW Echinocandins Antifungal Drugs Market Size, By Value (2013-2023) 202
11.5 ROW Polyenes Antifungal Drugs Market Size, By Value (2013-2023) 202
11.6 ROW Other Antifungal Drugs Market Size, By Value (2013-2023) 202
11.7 ROW Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%) 204
11.7.1 ROW Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023) 204
11.7.2 ROW Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023) 204
11.7.3 ROW Candidiasis Antifungal Drugs Market Size, By Value (2013-2023) 204
11.7.4 ROW Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023) 204
12. Global Antifungal Drugs Market: Market Dynamics 205
12.1 Global Antifungal Drugs Market Drivers 206
12.2 Global Antifungal Drugs Market Restrains 211
12.3 Global Antifungal Drugs Market Trends 213
13. Porter Five Force Analysis 217
14. SWOT Analysis 218
15. Antifungal Market – Competitive Landscape 219
10

11. Table of Content
S.No Particulars Page No.
16. Company Profiles 222
16.1 Merck & Co. 223
16.2 Pfizer 225
16.3 GSK 227
16.4 Novartis 229
16.5 Abbott Laboratories 231
16.6 Astellas Pharma 233
16.7 Bayer 235
16.8 Sanofi 237
16.9 Kramer Laboratories 239
11

12. List of Figures
Figure No. Figure Title Page No.
Figure 1: Global Antifungal Drugs Market Size, By Value, 2013-2017 (USD Million) 41
Figure 2: Number of People Living With HIV, 2013-2017 44
Figure 3: Number of New Cases of Cancer, In 2018, By Type, (% of Total) 44
Figure 4: Estimated TB Incidences, By WHO Regions, 2016 45
Figure 5: Prevalence of Diagnosed Autoimmune Diseases, In 2018, By Selected Countries, (% of Total) 45
Figure 6: Burden of Antifungal Infections, By Type 45
Figure 7: Generic Market Value Share, In 2006 (Left) &2016 (Right), By Region 48
Figure 8: Global Prescription and OTC Drugs Sales, 2013-2017, (USD Billion) 49
Figure 9: Expected Global Medical Spending in 2020, By Product Type, (% of Total) 49
Figure 10: Expected Global Medical Spending in 2020, By Region, (% of Total) 49
Figure 11: Global Aged Population (Above 65), 2013-2017 (% of total) 50
Figure 12: Global Aged Population(Above 65), By Country, 2017 (% of total) 50
Figure 13: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %) 51
Figure 14: GDP Per Capita PPP, By Region, 2018 (in Thousand USD) 51
Figure 15: Global Expected Healthcare Industry Outlook 52
Figure 16: Regional Expected Healthcare Industry Growth Rate By Year 2020 52
Figure 17: Global Antifungal Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million) 53
Figure 18: Global Antifungal Drugs Market Size, By Drug Class, 2017 (%) 55
Figure 19: Global Antifungal Drugs Market Size, By Drug Class, 2023F (%) 56
Figure 20: Global Azoles Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 57
12

13. List of Figures
Figure No. Figure Title Page No.
Figure 21: Global Azoles Antifungal Drugs Market, By Value, 2018-2023(USD Million) 57
Figure 22: Global Echinocandins Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 58
Figure 23: Global Echinocandins Antifungal Drugs Market, 2018-2023(USD Million) 58
Figure 24: Global Polyenes Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 59
Figure 25: Global Polyenes Antifungal Drugs Market, By Value, 2018-2023(USD Million) 59
Figure 26: Global Other Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 60
Figure 27: Global Other Antifungal Drugs Market, By Value, 2018-2023(USD Million) 60
Figure 28: Market Comparison Chart, By Product Type, 2013-2023 (USD Million) 61
Figure 29: Global Market Attractiveness, By Product Type, 2023F 62
Figure 30: Global Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 64
Figure 31: Global Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 64
Figure 32: Global Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 65
Figure 33: Global Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 65
Figure 34: Global Antifungal Drugs Market Size, By Region, 2017 (%) 67
Figure 35: Global Antifungal Drugs Market Size, By Region, 2023F (%) 67
Figure 36: North America Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 69
Figure 37: United States Spending on Medicines, 2013-2017 (In USD Billion) 71
Figure 38: Patented and Non-Patented Drugs Sales in Canada, 2013-2016 (USD Billion) 71
Figure 39: North America Diseases Outlook 72
Figure 40: United States health care expenditure per capita,2013-2016(USD) 72
13

14. List of Figures
Figure No. Figure Title Page No.
Figure 41: Canada health care expenditure per capita,2013-2016(USD) 72
Figure 42: North America population aged 65 and above, 2013-2017 (% of total) 73
Figure 43: North America Healthcare Cost Per Capita, 2017 (USD) 73
Figure 44: North America GDP per Capita, 2013-2017 (USD) 73
Figure 45: North America Antifungal Drugs Market, By Value, 2018-2023 (USD Million) 75
Figure 46: North America Antifungal Drugs Market Size, By Drug Class, 2017 (%) 75
Figure 47: North America Antifungal Drugs Market Size, By Drug Class, 2023F (%) 75
Figure 48: North America Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 76
Figure 49: North America Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 77
Figure 50: North America Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 77
Figure 51: North America Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 78
Figure 52: North America Antifungal Drugs Market,By Therapeutic Indications , By Value, 2013-2017 (USD Million) 78
Figure 53: North America Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 81
Figure 54: North America Antifungal Drugs Market Size, By Countries, 2023F (%) 81
Figure 55: USA Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 83
Figure 56: USA Antifungal Drugs Market, By Value, 2018-2023(USD Million) 83
Figure 57: United States Fungal Infection Facts & Figures 85
Figure 58: New Patients Diagnosed with HIV in 2017, By Age Group 85
Figure 59: United States Per Capita Spending on Medicines, 2013-2017 (In USD) 86
Figure 60: Pharmacy & Drug Store Sales in United States, 2013-2016 (In USD Billion) 86
14

15. List of Figures
Figure No. Figure Title Page No.
Figure 61: Medical and Healthcare Research & Development Spending, 2013-2016 (In USD Million) 86
Figure 62: U.S., Population ages 65 and above, 2013-2017 (% of total) 87
Figure 63: U.S., Population ages 65 and above, Forecast (In Millions) 87
Figure 64: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD) 87
Figure 65: U.S., GDP (Current USD), 2013-2017 (In USD Trillion) 87
Figure 66: USA Antifungal Drugs Market Size, By Drug Class, 2017 (%) 88
Figure 67: USA Antifungal Drugs Market Size, By Drug Class, 2023F (%) 88
Figure 68: USA Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 89
Figure 69: USA Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 90
Figure 70: USA Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 90
Figure 71: USA Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 91
Figure 72: USA Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 91
Figure 73: Leading Antifungal Drugs Companies In The United States of America 92
Figure 74: Canada Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 94
Figure 75: Canada Antifungal Drugs Market, By Value, 2018-2023(USD Million) 94
Figure 76: Estimated Number of Serious Fungal Infections Cases in Canada, 2014 95
Figure 77: Estimated Number of Mucosal Candidiasis in Canada, 2014 96
Figure 78: Estimated Number of Opportunistic Invasive Fungal Infections Cases in Canada, 2014 96
Figure 79: Estimated Number of Endemic Mycoses Cases in Canada, 2014 96
Figure 80: Estimated Number of Non-Invasive Pulmonary Aspergillosis Cases in Canada, 2014 96
15

16. List of Figures
Figure No. Figure Title Page No.
Figure 81: Number of Retail Pharmacies in Canada, 2013-2017 97
Figure 82: Number of Hospitals Establishments in Canada, By Province, 2015 97
Figure 83: Number HIV Cases in Canada, 2013-2016 97
Figure 84: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %) 98
Figure 85: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD) 98
Figure 86: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD) 98
Figure 87: Canada Antifungal Drugs Market Size, By Drug Class, 2017 (%) 99
Figure 88: Canada Antifungal Drugs Market Size, By Drug Class, 2023F (%) 99
Figure 89: Canada Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 100
Figure 90: Canada Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 101
Figure 91: Canada Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 101
Figure 92: Canada Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 102
Figure 93: Canada Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 102
Figure 94: Leading Antifungal Drugs Companies In Canada 103
Figure 95: Europe Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 105
Figure 96: Europe Health Expenditure, By Select Country, 2016 (% of GDP) 107
Figure 97: Europe Population ages 65 years and above (% of total population), 2013-17 107
Figure 98: Europe, Fungal Infections Burden, (Per 100000 population), By Selected Countries 108
Figure 99: Europe Antifungal Drugs Market, By Value, 2018-2023 (USD Million) 109
Figure 100: Europe Antifungal Drugs Market Size, By Drug Class, 2017 (%) 110
16

17. List of Figures
Figure No. Figure Title Page No.
Figure 101: Europe Antifungal Drugs Market Size, By Drug Class, 2023F (%) 110
Figure 102: Europe Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 111
Figure 103: Europe Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 112
Figure 104: Europe Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 112
Figure 105: Europe Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 113
Figure 106: Europe Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 113
Figure 107: Europe Antifungal Drugs Market Size, By Countries, 2017 (%) 116
Figure 108: Europe Antifungal Drugs Market Size, By Countries, 2023F (%) 116
Figure 109: Germany Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 118
Figure 110: Germany Antifungal Drugs Market, By Value, 2018-2023(USD Million) 118
Figure 111: Germany, Healthcare Related Statistics, 2017 119
Figure 112: Germany, Leukemia Incidences, 2014 & 2018E 121
Figure 113: Germany, Population ages 65 and above, 2012-2017 (% total) 121
Figure 114: Germany, Cause of Deaths, Percentage Change ,2007-2017 121
Figure 115: Germany, Cause of Deaths, Percentage Change ,2007-2017 121
Figure 116: Germany, HIV Prevalence, 2013-2017 122
Figure 117: Germany, Prevalence of Cancer, 2018 (% of total) 122
Figure 118: Germany Antifungal Drugs Market Size, By Drug Class, 2017 (%) 123
Figure 119: Germany Antifungal Drugs Market Size, By Drug Class, 2023F (%) 123
Figure 120: Germany Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 124
17

18. List of Figures
Figure No. Figure Title Page No.
Figure 121: Germany Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 125
Figure 122: Germany Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 125
Figure 123: Germany Antifungal Drugs Market, By herapeutic Indications , By Value, 2013-2017 (USD Million) 126
Figure 124: Germany Antifungal Drugs Market, By herapeutic Indications , By Value, 2013-2017 (USD Million) 126
Figure 125: Leading Antifungal Drugs Companies In Germany 127
Figure 126: France Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 129
Figure 127: France Antifungal Drugs Market, By Value, 2018-2023(USD Million) 129
Figure 128: France, Healthcare Infrastructure Related Statistics 130
Figure 129: France, Health Expenditure, (% of GDP), 2012-2015 (USD) 132
Figure 130: France, Population Ages 65 and Above (% of total), 2012-2017 132
Figure 131: France, Prevalence of Cancer, 2018, (% of total) 132
Figure 132: France, Spending on Healthcare, 2015 & 2040$, (USD Per Person) 132
Figure 133: France Antifungal Drugs Market Size, By Drug Class, 2017 (%) 133
Figure 134: France Antifungal Drugs Market Size, By Drug Class, 2023F (%) 133
Figure 135: France Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 134
Figure 136: France Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 135
Figure 137: France Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 135
Figure 138: France Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 136
Figure 139: France Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 136
Figure 140: Leading Antifungal Drugs Companies In France 137
18

19. List of Figures
Figure No. Figure Title Page No.
Figure 141: U.K Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 139
Figure 142: U.K Antifungal Drugs Market, By Value, 2018-2023(USD Million) 139
Figure 143: U.K, Health Expenditure, (% of GDP), 2013-2017 (USD) 141
Figure 144: U.K, Population Ages 65 and Above (% of total), 2012-2017 141
Figure 145: UK, Prevalence of Cancer, 2018, (% of Total) 141
Figure 146: U.K, Spending on Healthcare, 2015 & 2040, (USD Per Person) 141
Figure 147: UK, Healthcare Infrastructure Related Statistics 142
Figure 148: Candidaemia per 100,000 population by region (England, Wales and Northern Ireland), 2013-2017 142
Figure 149: U.K Antifungal Drugs Market Size, By Drug Class, 2017 (%) 143
Figure 150: U.K Antifungal Drugs Market Size, By Drug Class, 2023F (%) 143
Figure 151: U.K Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 144
Figure 152: U.K Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 145
Figure 153: U.K Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 145
Figure 154: U.K Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 146
Figure 155: U.K Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 146
Figure 156: Leading Antifungal Drugs Companies In U.K 147
Figure 157: APAC Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 149
Figure 158: GDP Per Capita in APAC, By Select Country, 2016 (In USD) 151
Figure 159: Population ages 65 and above, By Select Country, 2017 (% of total) 151
Figure 160: Cancer Incidences in Asia, (% of Total), 2018 151
19

20. List of Figures
Figure No. Figure Title Page No.
Figure 161: China, Pharmaceuticals Industry Revenue (USD Billion) 152
Figure 162: Japan, Total Drugs Market, 2013-2017, USD Billion 152
Figure 163: India Pharma Market, 2015-2017, (USD Billion) 152
Figure 164: APAC Antifungal Drugs Market, By Value, 2018-2023 (USD Million) 153
Figure 165: APAC Antifungal Drugs Market Size, By Drug Class, 2017 (%) 154
Figure 166: APAC Antifungal Drugs Market Size, By Drug Class, 2023F (%) 154
Figure 167: APAC Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 155
Figure 168: APAC Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 156
Figure 169: APAC Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 156
Figure 170: APAC Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 157
Figure 171: APAC Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 157
Figure 172: APAC Antifungal Drugs Market Size, By Countries, 2017 (%) 159
Figure 173: APAC Antifungal Drugs Market Size, By Countries, 2023F (%) 159
Figure 174: China Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 162
Figure 175: China Antifungal Drugs Market, By Value, 2018-2023(USD Million) 162
Figure 176: China, Fungal Infections Facts & Figures 164
Figure 177: China, Number of HIV Patients 165
Figure 178: China, Cancer Incidences ( in Million) 165
Figure 179: China, GDP Growth Per Year, 2015-2019 (In %) 166
Figure 180: China, Share of Urban Population, 2012-2017 (In %) 166
20

21. List of Figures
Figure No. Figure Title Page No.
Figure 181: China, Total Population, 2013-2021F (In Billion) 166
Figure 182: China Antifungal Drugs Market Size, By Drug Class, 2017 (%) 167
Figure 183: China Antifungal Drugs Market Size, By Drug Class, 2023F (%) 167
Figure 184: China Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 168
Figure 185: China Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 169
Figure 186: China Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 169
Figure 187: China Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 170
Figure 188: China Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 170
Figure 189: Leading Antifungal Drugs Companies In China 171
Figure 190: Japan Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 173
Figure 191: Japan Antifungal Drugs Market, By Value, 2018-2023(USD Million) 173
Figure 192: Japan, Population ages 65 and above, 2012-2017 (% of total) 174
Figure 193: Japan, HIV Prevalence, 2017 176
Figure 194: Japan, Medical Facilities Outlook 176
Figure 195: Japan Healthcare Expenditure Outlook (%) 176
Figure 196: Japan, GDP Growth Per Year, 2015-2019F (In %) 177
Figure 197: Japan, Population ages 65 and above, 2012-2016 (% of total) 177
Figure 198: Japan Antifungal Drugs Market Size, By Drug Class, 2017 (%) 178
Figure 199: Japan Antifungal Drugs Market Size, By Drug Class, 2023F (%) 178
Figure 200: Japan Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 179
21

22. List of Figures
Figure No. Figure Title Page No.
Figure 201: Japan Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 180
Figure 202: Japan Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 180
Figure 203: Japan Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 181
Figure 204: Japan Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023 (USD Million) 181
Figure 205: Leading Antifungal Drugs Companies In Japan 182
Figure 206: India Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 184
Figure 207: India Antifungal Drugs Market, By Value, 2018-2023(USD Million) 184
Figure 208: India, Fungal Infection Facts & Figures 186
Figure 209: India, Diseases & Medical Industry Outlook 186
Figure 210: India, Population ages 65 and above, 2013-2017 187
Figure 211: India, Total Population, 2013-2023F (In Billion) 187
Figure 212: Pharma Export From India Market, 2013-2017, (USD Billion) 187
Figure 213: India Antifungal Drugs Market Size, By Drug Class, 2017 (%) 188
Figure 214: India Antifungal Drugs Market Size, By Drug Class, 2023F (%) 188
Figure 215: India Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 189
Figure 216: India Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 190
Figure 217: India Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 190
Figure 218: India Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million) 191
Figure 219: India Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 191
Figure 220: Leading Antifungal Drugs Companies In India 192
22

23. List of Figures
Figure No. Figure Title Page No.
Figure 221: ROW Antifungal Drugs Market, By Value, 2013-2017 (USD Million) 194
Figure 222: Fungal Infection Burden in Latin America & Egypt, By Selected Countries 196
Figure 223: HIV Prevalence in LA&C and MENA (% of total), 2018 197
Figure 224: Cancer Prevalence in MENA (% of total), 2018 197
Figure 225: Cancer Prevalence in Latin America & Caribbean , (% of total), 2018 197
Figure 226: GDP Per Capita in ROW, By Select Country, 2013 (In USD) 198
Figure 227: GDP Per Capita in ROW, By Select Country, 2017 (In USD) 198
Figure 228: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total) 199
Figure 229: Middle East and North Africa, Population ages 65 and above (% of total) 199
Figure 230: ROW Antifungal Drugs Market, By Value, 2018-2023 (USD Million) 200
Figure 231: ROW Antifungal Drugs Market Size, By Drug Class, 2017 (%) 201
Figure 232: ROW Antifungal Drugs Market Size, By Drug Class, 2023F (%) 201
Figure 233: ROW Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million) 202
Figure 234: ROW Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%) 203
Figure 235: ROW Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%) 203
Figure 236: ROW Antifungal Drugs Market,By Therapeutic Indications , By Value, 2013-2017 (USD Million) 204
Figure 237: ROW Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million) 204
Figure 238: Branded Antifungal Drugs Sales, 2017, (USD Million) 221
Figure 239: Merck & Co., Revenues 2013-2017(USD Million) 224
Figure 240: Merck & Co., Revenues, By Region, 2017(% of Total) 224
23

24. List of Figures
Figure No. Figure Title Page No.
Figure 241: Merck & Co., Revenues, By Region, 2017(% of Total) 224
Figure 242: Pfizer, Net Sales, 2013-2017 (USD Million) 226
Figure 243: Pfizer, Revenue, By Segments, 2017 (%) 226
Figure 244: Vfend, Net Sales, 2015-2017 (USD Million) 226
Figure 245: GSK, Revenues, 2013-2017 (USD Million) 228
Figure 246: GSK, Revenue, By Region, 2017 (USD Million) 228
Figure 247: GSK, Revenue, By Segments, 2017(%) 228
Figure 248: GSK, Revenue, By Pharmaceuticals Segment, 2017 (USD Million) 228
Figure 249: Novartis, Net Sales, 2013-2017 (USD Million) 230
Figure 250: Novartis, Revenue, By Segment, 2017(%) 230
Figure 251: Novartis, Revenue, By Region, 2017(%) 230
Figure 252: Abbott Laboratories, Net Sales, 2013-2017 (USD Million) 232
Figure 253: Abbott Laboratories, Revenue, By Segments, 2017(%) 232
Figure 254: Abbott Laboratories, Revenue, By Regions, 2017(%) 232
Figure 255: Astellas, Net Sales, 2013-2017 (USD Million) 234
Figure 256: Astellas, Revenue, By Regions, 2017(%) 234
Figure 257: Astellas, Revenue, By Segments, 2017(%) 234
Figure 258: Bayer, Net Sales, 2013-2017 (USD Million) 236
Figure 259: Bayer, Net Sales, 2013-2017 (USD Million) 236
Figure 260: Bayer, Revenue, By Segments, 2017(%) 236
24

25. List of Figures
Figure No. Figure Title Page No.
Figure 261: Sanofi, Net Sales, 2013-2017 (USD Million) 238
Figure 262: Bio-Rad Revenue, By Region, 2017(%) 238
25

26. List of Figures
Figure No. Figure Title Page No.
Table 1: Different Types of Common Fungal Diseases 36
Table 2: Different Class of Anti-Fungal Drugs 37
Table 3: Common Invasive Fungal Diseases and Their Treatment Options 38
Table 4: Common Invasive Fungal Diseases and Their Treatment Options 39
Table 5: Burden of Fungal Diseases 43
Table 6: Antifungal Compounds in Development Stage – By Phases 47
Table 7: EU-5 Socio-Economical Statistics, 2017 48
Table 8: Germany, Fungal Infection Burden 120
Table 9: France, Fungal Infection Burden 131
Table 10: Invasive Fungal Infection Burden In UK 140
Table 11: Estimated Antifungal Prevalence in Japan, 2016 175
Table 12: Percentage aged 60 years and over, (2000, 2015, 2030,2050) 210
Table 13: Competitive Landscape - Leading Companies – Sales by Drug Class 220
26

27. For our study on Global Antifungal Drugs market, we have conducted comprehensive secondary research
followed by an extensive primary research. In the process of secondary research, we have scrutinized
industry documents, accessed from open sources, premium databases (Bloomberg, Thomson Reuters,
Factiva, Evaluate Pharma, NCBI) and our internal knowledge base. In the process of primary research, we
have interviewed various industry experts across the value chain of medical industry.
Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the
industry in the last five years, and confirming the findings through primary research. Annual reports of the
companies were scanned to further validate the market size and to estimate the size of various other end-
user sectors. Market sizing and growth in the forecast period (2018-2023) is estimated through product
mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the
industry. All the relevant data points/ statistics in the forecast period are validated through relevant and
reliable primary sources.
Report Focus: Global Antifungal Drugs
By Drug Type: Azoles, Polyenes, Echinocandins, Others
By Therapeutic Indications: Aspergillosis, Candidiasis, Dermatophytosis, Others
By Region: North America, Europe, APAC and ROW.
By Country: USA, Canada, Germany, France, UK, China, Japan and India.
Research Methodology
27

28. Global Antifungal Drugs Market
Source: Azoth Analytics Estimates
Xx
Xx
Xx
Xx
Xx
CAGR: 2013-2017
xx%
2013 2014 2015 2016 2017
Figure 1: Global Antifungal Drugs Market Size, By Value, 2013-2017 (USD Million)
xx
28

29. Global Antifungal Drugs Market
Source: Azoth Analytics Estimates
CAGR: 2018-2023
xx%
2018 2019 2020 2021 2022 2023
Figure 17: Global Antifungal Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
Xx
Xx
Xx
Xx
Xx
Xx
xx
xx
29

30. Global Antifungal Drugs Market- By Drug Class
Figure 18: Global Antifungal Drugs Market Size,
By Drug Class, 2017 (%)
Source: Azoth Analytics Estimates
Key Drivers
xx
xx
xx
Azoles Echinocandins Polyenes Others
Xx
30

31. Global Antifungal Drugs Market- By Drug Class
Figure 19: Global Antifungal Drugs Market Size,
By Drug Class, 2023F (%)
Source: Azoth Analytics Estimates
xxx
31
Key Drivers
xx
xx
xx
Azoles Echinocandins Polyenes Others

32. Global Insulin Pumps Market, By Value
Figure 20: Global Azoles Antifungal Drugs Market, By
Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
Figure 21: Global Azoles Antifungal Drugs Market,
By Value, 2018-2023(USD Million)
Global Azole Antifungal Drugs Market
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
32

33. Global Insulin Pumps Market, By Value
Figure 22: Global Echinocandins Antifungal Drugs
Market, By Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
Figure 23: Global Echinocandins Antifungal Drugs
Market, 2018-2023(USD Million)
Global Echinocandins Antifungal Drugs Market
33
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

34. Global Insulin Pumps Market, By Value
Figure 24: Global Polyenes Antifungal Drugs Market,
By Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
Figure 25: Global Polyenes Antifungal Drugs Market,
By Value, 2018-2023(USD Million)
Global Polyenes Antifungal Drugs Market
34
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

35. Global Insulin Pumps Market, By Value
Figure 26: Global Other Antifungal Drugs Market, By
Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
Figure 27: Global Other Antifungal Drugs Market, By
Value, 2018-2023(USD Million)
Global Others Antifungal Drugs Market
35
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%

36. Global Antifungal Drugs Market- Market Attractiveness
Source: Azoth Analytics Estimates
Azoles demand is expected to remain …
Xx
Xx
Xx
Xx
Xx
Figure 29: Global Market Attractiveness, By Product Type, 2023F
Azoles
Echinocandins
Polyenes
CompoundAnnualGrowthRate
Market Size (USD Million)
Others
36

37. Global Antifungal Drugs Market- By Application
Figure 30: Global Antifungal Drugs Market Size,
By Therapeutic Indications , 2017 (%)
Source: Azoth Analytics Estimates
Aspergillosis Dermatophytosis Candidiasis Others
Figure 31: Global Antifungal Drugs Market Size, By
Therapeutic Indications , 2023F (%)
Source: Azoth Analytics Estimates
Aspergillosis Dermatophytosis Candidiasis Others
Candidiasis fungal infections has been providing largest share to the antifungal manufacturers.
37

38. North America Insulin Pumps Market, By Value
Figure 32: Global Antifungal Drugs Market, By Therapeutic
Indications , By Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
Figure 33: Global Antifungal Drugs Market, By Therapeutic
Indications , By Value, 2018-2023(USD Million)
Global Antifungal Drugs Market, By Therapeutic Indications
38
CAGR 2013-2017
Aspergillosis: xx%
Dermatophytosis: xx%
Candidiasis: xx%
Other:x xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Aspergillosis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dermatophytosis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Candidiasis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2018-2023
Aspergillosis: xx%
Dermatophytosis: xx%
Candidiasis: xx%
Other: xx%
Xx
Xx
Xx
Xx
Xx

39. Global Antifungal Drugs Market - Regional Analysis
Figure 34: Global Antifungal Drugs Market Size,
By Region, 2017 (%)
Source: Azoth Analytics Estimates
Figure 35: Global Antifungal Drugs Market Size,
By Region, 2023F (%)
Source: Azoth Analytics Estimates
North America Europe APAC ROW
North America dominates the global market and expected to create its dominance till 2023, while APAC
is expected to increase in forecast period.
39
North America Europe APAC ROW

40. North America Antifungal Drugs Market
Source: Azoth Analytics Estimates
Figure 36: North America Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
xx
40
Xx
Xx
Xx
Xx
Xx
CAGR: 2013-2017
xx%
2013 2014 2015 2016 2017

41. North America Antifungal Drugs Market
Source: Azoth Analytics Estimates
Figure 45: North America Antifungal Drugs Market, By Value, 2018-2023 (USD Million)
xx
41
CAGR: 2018-2023
xx%
2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
xx

42. Global Insulin Pumps Market, By Value
Figure 48: North America Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
CAGR 2013-2017
Azoles: xx%
Echinocandins: xx%
Polyenes: xx%
Others: xx%
North America Antifungal Drugs Market- By Drug Class
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Azoles 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Echinocandins 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Polyenes 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2018-2023
Azoles: xx%
Echinocandins: xx%
Polyenes: xx%
Others: xx%
Xx
Xx
Xx
Xx
Xx
42

43. North America Antifungal Drugs Market- By Therapeutic Indications
Figure 49: North America Antifungal Drugs Market
Size, By Therapeutic Indications , 2017 (%)
Source: Azoth Analytics Estimates
Aspergillosis Dermatophytosis Candidiasis Others
Figure 50: North America Antifungal Drugs Market
Size, By Therapeutic Indications , 2023F (%)
Source: Azoth Analytics Estimates
Aspergillosis Dermatophytosis Candidiasis Others
xx
43

44. North America Insulin Pumps Market, By Value
Figure 51: North America Antifungal Drugs Market,
By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
CAGR 2013-2017
Aspergillosis: xx%
Dermatophytosis: xx%
Candidiasis: xx%
Other:x xx%
Figure 52: North America Antifungal Drugs Market,
By Therapeutic Indications , By Value, 2018-2023(USD Million)
North America Antifungal Drugs Market, By Therapeutic Indications
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Aspergillosis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dermatophytosis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Candidiasis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2018-2023
Aspergillosis: xx%
Dermatophytosis: xx%
Candidiasis: xx%
Other: xx%
Xx
Xx
Xx
Xx
Xx
44

45. Global Insulin Pumps Market, By Value
Figure 55: USA Antifungal Drugs Market, By Value,
2013-2017 (USD Million)
Source: Azoth Analytics Estimates
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
Figure 56: USA Antifungal Drugs Market, By Value,
2018-2023(USD Million)
USA Antifungal Drugs Market
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
45

46. Global Insulin Pumps Market, By Value
Figure 68: USA Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
USA Antifungal Drugs Market- By Drug Class
46
CAGR 2013-2017
Azoles: xx%
Echinocandins: xx%
Polyenes: xx%
Others: xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Azoles 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Echinocandins 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Polyenes 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2018-2023
Azoles: xx%
Echinocandins: xx%
Polyenes: xx%
Others: xx%
Xx
Xx
Xx
Xx
Xx

47. USA Antifungal Drugs Market- By Therapeutic Indications
Figure 69: USA Antifungal Drugs Market Size,
By Therapeutic Indications , 2017 (%)
Source: Azoth Analytics Estimates
Figure 70: USA Antifungal Drugs Market Size,
By Therapeutic Indications , 2023F (%)
Source: Azoth Analytics Estimates
47
Aspergillosis Dermatophytosis Candidiasis OthersAspergillosis Dermatophytosis Candidiasis Others

48. USA Insulin Pumps Market, By Value
Figure 71: USA Antifungal Drugs Market, By Therapeutic
Indications , By Value, 2013-2017 (USD Million)
Source: Azoth Analytics Estimates
Figure 72: USA Antifungal Drugs Market, By Therapeutic
Indications , By Value, 2018-2023(USD Million)
USA Antifungal Drugs Market, By Therapeutic Indications
48
CAGR 2013-2017
Aspergillosis: xx%
Dermatophytosis: xx%
Candidiasis: xx%
Other:x xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Aspergillosis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dermatophytosis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Candidiasis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2018-2023
Aspergillosis: xx%
Dermatophytosis: xx%
Candidiasis: xx%
Other: xx%
Xx
Xx
Xx
Xx
Xx

49. About Azoth Analytics Pvt Ltd.
Azoth Analytics (ISO 9001:2015) is a business research and analytics company that creates in-depth research reports and provides customized research
solutions and consulting services. An ISO 9001:2015 certified company, Azoth Analytics adheres to international quality management standard and has strong
commitment to a culture of continuous improvement. The business research and market analysis of Azoth Analytics helps organizations across different
industry verticals solve their business problems. Strategic market sizing and data dredging techniques include secondary research, and primary research
(interviews with management personnel and industry experts). Azoth Analytics provide syndicated and customized market research reports on different
verticals including pharmaceutical and healthcare, oil and gas and power, chemicals, automotive, technology, FMCG, food & beverages and media sectors.
Recent Azoth Analytics Reports
• Global Advanced Wound Care Market: Analysis By Type (Advanced Wound Dressings, Wound Therapy Devices, Wound Biologics), By
Application (Chronic Wounds, Acute Wounds), By End-User, By Region, By Country (2018 Edition): Opportunities and Forecasts (2018-
2023)
• Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition):
Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs,
Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)
• Global Transdermal Drug Delivery System Market: Analysis By Type (Patches, Gels), By Technique (Ionophoresis, Electroporation,
Sonophoresis, Others), By End-User, By Region, By Country (2018 Edition): Trends, Opportunities and Forecast (2013-2023)
49